Poster Abstract Session:
44. Fungal Diagnostics and Therapy
Thursday, October 18, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: M. Clinical Mycology

Tracks: Adult ID, Investigative ID


Immunotherapy-A New Treatment Strategy in Human Ocular Pythiosis
Nitipong Permpalung, M.D. ; Usanee Reinprayoon, M.D. ; Rongpong Plongla, M.D. ; Ngamjit Kasetsuwan, M.D. ; Arsa Thammahong, M.D. ; Leonel Mendoza, Ph.D. ; Ariya Chindamporn, Ph.D.
  • Immunotherapy.pdf (3.8 MB)

  • 222
    Customized Induction Therapy for the Treatment of Cryptococcal Meningitis Based on Initial Fungal Burden
    Joshua Rhein, MD ; Radha Rajasingham ; Melissa Rolfes ; David Meya ; David Boulware, MD, MPH

    Liver Safety of Posaconazole in Early Salvage Therapy for Invasive Fungal Infections Caused by Molds and Yeasts
    Shariq Haider, MD, FRCPC ; Michel Laverdière, MD ; Coleman Rotstein, MD ; Shahid Husain, MD, MS ; Karen Doucette, MD ; Maryse Power, MD ; Jeffrey Lipton, MD, PhD ; Peter Phillips, MD ; Andre Galarneau, Ph.D. ; Jean-Francois Pouliot, Ph.D.

    Echinocandin Resistance in Candida Glabrata Acquired Through the FKS1 Hotspot Mutation
    Stacy Newman, MD ; Kristi Traugott, PharmD, BCPS ; Julia Garcia-Diaz, MD ; George A. Pankey, MD

    Sensitivity of Galactomannan Enzyme Immunoassay for diagnosing breakthrough invasive Aspergillosis under Mould-active antifungal prophylaxis/therapy
    Martin Hoenigl, MD ; Thomas Valentin, MD ; Katharina Seeber, PharmD ; Walter Buzina ; Wiebke Duettmann, MD ; Jasmin Wagner, MD ; Volker Strenger, MD ; Robert Krause, MD

    Caspofungin  and  Voriconazole as Primary and Salvage Therapy for Patients with Invasive Aspergillosis  in Hematologic Malignany
    Ray Hachem, MD ; Gilbert El Helou, MD ; Aline El Zakhem, MD ; William Shomali, MD ; Ying Jiang, MS ; Anne-Marie Chaftari, MD ; Issam Raad, MD
  • Caspo.pdf (238.0 kB)

  • 228
    Routine CSF analysis based solely on coccidioidal CF antibody titers should not be recommended
    George R. Thompson III, MD ; Sharon Wang, DO ; Robert Bercovitch, MD ; Michael Bolaris, MD ; Dane Van Den Akker, MD ; Rodrigo Lopez, MD ; Antonio Catanzaro ; Jose Cadena, MD ; Peter Chin-Hong, MD ; Brad Spellberg, MD, FIDSA

    In Vitro Toxicity and Activity of Mafenide Acetate (MA) and Amphotericin B (AB) on Filamentous Fungi and Human Cells
    Alice Barsoumian, MD ; Carlos Sanchez Jr., PhD ; Katrin Mende, PhD ; Miriam Beckius, MPH ; Kevin S. Akers, MD ; Joseph Wenke, PhD ; Clinton Murray, MD

    In Vitro Activity and Safety of Topical Dakin’s Solution (Buffered Sodium Hypochlorite) on Filamentous Fungi and Human Cells
    Alice Barsoumian, MD ; Katrin Mende, PhD ; Carlos Sanchez Jr., PhD ; Miriam Beckius, MPH ; Kevin S. Akers, MD ; Joseph Wenke, PhD ; Clinton Murray, MD

    Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis
    Louis Chai, MD, PhD ; Bart Jan Kullberg, MD PhD ; Elizabeth Johnson, PhD ; Lay Wai Khin, MD ; Steven Teerenstra, PhD ; Alieke Vonk, MD, PhD ; Haran Schlamm, MD ; Peter Troke, PhD ; Mihai Netea, MD, PhD ; Raoul Herbrecht, MD, PhD

    Test performance of a novel lateral-flow assay to detect Cryptococcal disease
    Tara Vijayan, MD ; Sean K. Bauman, PhD ; Tom Chiller, MD, MPH ; Jeffrey Klausner, MD
  • LFAIDSA2012poster10-12.pdf (1.2 MB)

  • 233
    Voriconazole Therapeutic Drug Monitoring in hematologic and ICU Patients with Invasive Aspergillosis
    Martin Hoenigl, MD ; Reinhard B. Raggam, MD ; Thomas Valentin, MD ; Katharina Seeber, PharmD ; Holger Flick, MD ; Jasmin Wagner, MD ; Ines Zollner-Schwetz, MD ; Robert Krause, MD

    Clinical Impact of the Direct Sputum Nucleic Acid Amplification Test (NAAT) for the Diagnosis of Tuberculosis (TB)
    Jaimin Patel, DO ; Pablo Buitron de la Vega, MD ; Sravana Kumar Reddy Jeepalyem, Medical student ; Gladys Macabga, DO ; Angela Kieca ; Laura Johnson, MD ; Linoj Samuel, PhD ; George Alangaden, MD

    CME Credits:

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.